The US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Continue reading »
Home »
Ramace
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RAMACE® Ramipril Consumer Medicine Information What is
Continue reading »
Fampyra
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. FAMPYRA – CMI 11016 (fam-peer-a) Fampridine (fam-pri-deen)
Continue reading »
APO-Zoledronic Acid
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-ZOLEDRONIC ACID SOLUTION FOR INFUSION Zoledronic acid
Continue reading »
Apohealth Bisacodyl Laxative
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APOHEALTH Bisacodyl Tablets Contains the active ingredientbisacodyl
Continue reading »
Galvumet
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GALVUMET® Vildagliptin/Metformin hydrochloride Consumer Medicine Information What
Continue reading »
Imatinib-Teva
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. IMATINIB-TEVA® CMI VERSION 2.0 Imatinib (as mesilate)
Continue reading »
Chemmart Isosorbide Mononitrate
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART ISOSORBIDE MONONITRATE TABLETS Isosorbide mononitrate Consumer
Continue reading »
Chemmart Quetiapine
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART QUETIAPINE TABLETS Quetiapine fumarate Consumer Medicine
Continue reading »
Triumeq
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRIUMEQ Film-coated tablets 50 mg dolutegravir (as
Continue reading »